Biperiden is an anticholinergic agent used to manage drug-induced extrapyramidal symptoms and as adjunct therapy in Parkinson's disease. Simson Pharma's Biperiden reference standard and impurities support compendial QC for this neurology-focused therapeutic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Biperiden Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.